Bio-Modeling Systems SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Modeling Systems SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10535
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted deductive integration (CADI), which is used in the discovery of new medicines and cosmetics. Its CADI platform undertakes contract research and internal research production in the areas of infection-immunology, inflammation, industrial biotechnology, cancer, tissue differentiation, dermatology and matabolism among others. The company caters to several pharmaceutical, cosmetic, biotechnologies, medical devices and diagnostic companies, among others. It provides novel hypotheses discovery and novel therapeutics diagnostics solution. BM Systems is headquartered in Paris, France.

Bio-Modeling Systems SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Licensing Agreements 12
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS – Key Competitors 13
Bio-Modeling Systems SAS – Key Employees 14
Bio-Modeling Systems SAS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Key Facts 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS, Key Competitors 13
Bio-Modeling Systems SAS, Key Employees 14

List of Figures
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bio-Modeling Systems SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infineon Technologies AG:企業の戦略・SWOT・財務情報
    Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report Summary Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Perfint Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products for onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a computed tomography system; ROBIO …
  • Development Bank of Southern Africa:電力:M&Aディール及び事業提携情報
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報
    Summary Formosa Laboratories Inc (Formosa Laboratories) is a producer of active pharmaceutical ingredients and UV-filters. The company’s active pharmaceutical ingredients include cholesterol and phosphate binders, anticancers, CNS agents, immunomodulators, MRI enhancing agents, anti-inflammatory and …
  • Landesbank Berlin Holding Ag:企業の戦略・SWOT・財務分析
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Coca-Cola Icecek A.S.:企業の戦略・SWOT・財務情報
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Drummond Company Inc:企業の戦略・SWOT・財務情報
    Drummond Company Inc - Strategy, SWOT and Corporate Finance Report Summary Drummond Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PT Sinar Mas Agro Resources and Technology Tbk (SMAR):企業の財務・戦略的SWOT分析
    PT Sinar Mas Agro Resources and Technology Tbk (SMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Boral Limited:企業の戦略・SWOT・財務情報
    Boral Limited - Strategy, SWOT and Corporate Finance Report Summary Boral Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • FCA US LLC:企業の戦略的SWOT分析
    FCA US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • NTT Communications Corporation:戦略・SWOT・企業財務分析
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Noble Energy, Inc.:戦略・SWOT・企業財務分析
    Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Power Assets Holdings Ltd (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • CH&Co Group:企業の戦略・SWOT・財務分析
    CH&Co Group - Strategy, SWOT and Corporate Finance Report Summary CH&Co Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • Thin Film Electronics ASA (THIN):企業の財務・戦略的SWOT分析
    Thin Film Electronics ASA (THIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Spur Corporation Limited:企業の戦略・SWOT・財務分析
    Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆